SCA and Vinda deal approved
SCAs and the majority shareholder in China’s tissue company, Vinda International agreement with Vinda to transfer its hygiene business in China, has been approved by Vindas independent shareholders.
– The approved cooperation and transaction will generate mutual benefits for both SCA and Vinda particularly in distribution, sales, innovation and R&D, says Jan Johansson, President and CEO of SCA.
Vinda will get access to a broader product portfolio and SCA’s brands will have the potential to reach a broader base of consumers and customers via the extensive and robust distribution network of Vinda in China.
Vinda is listed on the Hong Kong Stock Exchange, and the agreement which strengthens the cooperation between SCA and Vinda was subject to approval by the independent shareholders of Vinda.